435 related articles for article (PubMed ID: 27217283)
1. Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study.
Mozaffary A; Asgari S; Tohidi M; Kazempour-Ardebili S; Azizi F; Hadaegh F
BMJ Open; 2016 May; 6(5):e010889. PubMed ID: 27217283
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictors of early adulthood pre-diabetes/type 2 diabetes, among Iranian adolescents: the Tehran Lipid and Glucose Study.
Mirbolouk M; Derakhshan A; Charkhchi P; Guity K; Azizi F; Hadaegh F
Pediatr Diabetes; 2016 Dec; 17(8):608-616. PubMed ID: 26764014
[TBL] [Abstract][Full Text] [Related]
3. Decision tree-based modelling for identification of potential interactions between type 2 diabetes risk factors: a decade follow-up in a Middle East prospective cohort study.
Ramezankhani A; Hadavandi E; Pournik O; Shahrabi J; Azizi F; Hadaegh F
BMJ Open; 2016 Dec; 6(12):e013336. PubMed ID: 27909038
[TBL] [Abstract][Full Text] [Related]
4. The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction.
Janghorbani M; Almasi SZ; Amini M
Acta Diabetol; 2015 Aug; 52(4):781-8. PubMed ID: 25572334
[TBL] [Abstract][Full Text] [Related]
5. Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
Kim JA; Lee JS; Chung HS; Roh E; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
Diabetes Care; 2018 Dec; 41(12):2610-2616. PubMed ID: 30254081
[TBL] [Abstract][Full Text] [Related]
6. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies.
Deravi N; Sharifi Y; Koohi F; Zadeh SST; Masrouri S; Azizi F; Hadaegh F
BMC Public Health; 2023 Mar; 23(1):565. PubMed ID: 36973769
[TBL] [Abstract][Full Text] [Related]
7. Serum total bile acids associate with risk of incident type 2 diabetes and longitudinal changes in glucose-related metabolic traits.
Zhu W; Wang S; Dai H; Xuan L; Deng C; Wang T; Zhao Z; Li M; Lu J; Xu Y; Chen Y; Wang W; Bi Y; Xu M; Ning G
J Diabetes; 2020 Aug; 12(8):616-625. PubMed ID: 32220107
[TBL] [Abstract][Full Text] [Related]
8. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F
Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
[TBL] [Abstract][Full Text] [Related]
9. Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with type 2 diabetes.
Faghihi-Kashani S; Bonnet F; Hafezi-Nejad N; Heidari B; Aghajani Nargesi A; Sheikhbahaei S; Ebadi M; Esteghamati A
Diabetes Metab; 2016 Feb; 42(1):55-61. PubMed ID: 26531321
[TBL] [Abstract][Full Text] [Related]
10. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.
Lee JW; Lim NK; Park HY
BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706
[TBL] [Abstract][Full Text] [Related]
11. The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men.
Park YW; Chang Y; Sung KC; Ryu S; Sung E; Kim WS
Diabetes Res Clin Pract; 2006 Sep; 73(3):329-35. PubMed ID: 16600415
[TBL] [Abstract][Full Text] [Related]
12. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study.
Tohidi M; Baghbani-Oskouei A; Ahanchi NS; Azizi F; Hadaegh F
Acta Diabetol; 2018 Oct; 55(10):1067-1074. PubMed ID: 30066042
[TBL] [Abstract][Full Text] [Related]
13. Fasting plasma glucose levels predict steroid-induced abnormal glucose metabolism in patients with non-diabetic chronic kidney disease: a prospective cohort study.
Yang X; Lin X; Lu T; Chen P; Wang X; Hou FF
Am J Nephrol; 2015; 41(2):107-15. PubMed ID: 25766034
[TBL] [Abstract][Full Text] [Related]
14. [Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study].
Yang XY; Zhang M; Luo XP; Wang JJ; Yin L; Pang C; Wang GA; Shen YX; Wu DT; Zhang L; Ren YC; Wang BY; Zhang HY; Zhou JM; Han CY; Zhao Y; Feng TP; Hu DS; Zhao JZ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):328-33. PubMed ID: 27029364
[TBL] [Abstract][Full Text] [Related]
15. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
Harati H; Hadaegh F; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
[TBL] [Abstract][Full Text] [Related]
16. Combining Fasting Plasma Glucose with Gamma-glutamyl Transferase Improves the Sensitivity to Predict Incident Diabetes in Asian Indian Men with Impaired Glucose Tolerance.
Nanditha A; Jagannathan R; Sundaram S; Susairaj P; Shetty AS; Snehalatha C; Ian GF; Johnston DG; Ramachandran A
J Assoc Physicians India; 2014 Nov; 62(11):18-22. PubMed ID: 26281475
[TBL] [Abstract][Full Text] [Related]
17. Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study.
Bozorgmanesh M; Hadaegh F; Saadat N; Azizi F
Acta Diabetol; 2012 Oct; 49(5):341-8. PubMed ID: 21617883
[TBL] [Abstract][Full Text] [Related]
18. Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.
Huang CL; Chang HW; Chang JB; Chen JH; Lin JD; Wu CZ; Pei D; Hung YJ; Lee CH; Chen YL; Hsieh CH
QJM; 2016 Aug; 109(8):515-22. PubMed ID: 26576838
[TBL] [Abstract][Full Text] [Related]
19. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan diabetes prevention study.
Janghorbani M; Soltanian N; Amini M; Aminorroaya A
Diabetes Metab Syndr; 2018 Sep; 12(5):715-719. PubMed ID: 29699950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
